Clinical trials during the prodromal stage of schizophrenia

被引：9

作者：

Addington, J

Addington, D

机构：

来源：

AMERICAN JOURNAL OF PSYCHIATRY | 2005年 / 162卷 / 07期

关键词：

D O I：

10.1176/appi.ajp.162.7.1387

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

收藏

页码：1387 / 1387

页数：1

相关论文

共 2 条

[1] The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis I. Study rationale and design [J].

McGlashan, TH ;

Zipursky, RB ;

Perkins, D ;

Addington, J ;

Miller, TJ ;

Woods, SW ;

Hawkins, KA ;

Hoffman, R ;

Lindborg, S ;

Tohen, M ;

Breier, A .

SCHIZOPHRENIA RESEARCH, 2003, 61 (01) :7-18

[2] Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms [J].

McGorry, PD ;

Yung, AR ;

Phillips, LJ ;

Yuen, HP ;

Francey, S ;

Cosgrave, EM ;

Germano, D ;

Bravin, J ;

McDonald, T ;

Blair, A ;

Adlard, S ;

Jackson, H .

ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (10) :921-928